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Background. The variable antigen P. falciparum erythrocyte membrane protein–1 (PfEMP1) is amajor virulence
factor in malaria. A large number of var genes encode PfEMP1, and we hypothesized that a restricted PfEMP1
repertoire determines clinical disease presentation. We conducted a case-control study in Papua New Guinea and
analyzed transcribed var genes in naturally infected children.
Methods. var messenger RNA was isolated from 78 children with asymptomatic, mild, or severe malaria. We
prepared complementary DNA from the upstream region into the DBL1a domain and picked, on average, 20
clones for sequencing.
Results. Twenty-fiv percent of centrally located var genes were shared between children, whereas only 5% of
subtelomeric genes were shared, indicating lower diversity in the former group. Linkage between group B or C
var upstream sequences and DBL1a groups was not observed, which impeded prediction by DBL1a analysis. A
higher proportion of var group A sequences was detected in symptomatic malaria, and a subgroup of frequently
encountered var genes with complex head structure seems to be associated with severe malaria. A subset of var
group C genes was frequently expressed in older children with asymptomatic high levels of parasitemia.
Conclusion. Despite this vast diversity, restricted disease-associated var genes were identifie and might be
used for innovative interventions based on PfEMP1.
Antigenic variation is an important evasion mechanism
associated with parasite sequestration and virulence in
Plasmodium falciparum malaria. The adherence of par-
asitized red blood cells to endothelial cells and to un-
infected erythrocytes (rosetting) is characteristic of P.
falciparum infection, leading to microvascular obstruc-
tions [1–3]. This is mediated by the variant surface
antigen P. falciparum erythrocyte membrane protein–1
(PfEMP1), which is encoded by 1 of approximately 60
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var genes [4]. var genes are classifie into 3 major
groups (i.e., var group A, B, and C) and 2 intermediate
groups (i.e., BA and BC) in accordance with their chro-
mosomal location and their 5′ upstream region [5]. var
group A and B genes are subtelomerically located, in
contrast var group C genes are arranged in the center
of chromosomes. Differences in transcriptional regu-
lation between var group B and C have been described
elsewhere [6] and might indicate differences in their
function.
PfEMP1 is structured into several domains with an
extracellular part composed of a variable N-terminal
segment (NTS), various Duffy binding–like domains
(DBL), and cysteine-rich interdomain regions [5].
These domains have been associated with different
binding specificitie for host receptors [7–10]. The ex-
tracellular part is followed by a transmembrane domain
and the conserved intracellular acidic terminal segment
that anchors the protein to the cytoskeleton [9, 11, 12].
PfEMP1 enables the parasite to avoid splenic clearance
by sequestration, but consequently it is presented to the
immune system, eliciting an immune response. There-
fore, the parasite undergoes antigenic variation by
switching expression to alternative PfEMP1s to subvert
348 • JID 2009:200 (1 August) • Falk et al.
Figure 1. var gene structure and polymerase chain reaction products generated with var group–specific 5′ UTR forward or DBL1a forward and
DBL1a reverse primer. ATS, acidic terminal segment; CIDR, cysteine-rich interdomain region; DBL, Duffy binding–like domain; NTS, N-terminal segment;
TM, transmembrane domain.
the immune response. This switch often changes the adhesive
properties [13].
Because of antigenic variation, PfEMP1 is often not consid-
ered a feasible malaria vaccine candidate. Recent studies, how-
ever, have shown that structural similarities exist in the mol-
ecule’s head structure [14], and only a few PfEMP1 variants
have been associated with certain clinical presentations, such
as pregnancy-associated malaria [15], in which variants bind
to chondroitin sulfate A. Other PfEMP1 molecules have been
associated with severe disease [16–19], for example, PfEMP1
molecules with DBL1-like domains lacking 1 or 2 of the cys-
teines characteristic of group A and B/A var genes [20,21]. Up-
regulation of group A and B var genes in children with severe
malaria was observed in Tanzania but not in Kenya [21, 22].
In Papua New Guinea, up-regulation of var group B genes was
evident in patients with severe malaria, but up-regulation of
var group A was not observed [23]. Despite inconsistencies,
these results support the notion that structures or a limited
number of disease-related var genes exist and that their iden-
tificatio would enable the development of interventions
against severe disease.
To study the association of expressed var genes and clinical
presentation of malaria, we analyzed the var transcripts of par-
asites recovered from children with severe, mild, or asymptom-
atic malaria in a case-control study in Papua New Guinea. var
messenger RNA (mRNA) was reverse transcribed and amplifie
with polymerase chain reaction (PCR), followed by cloning and
sequencing. Sequences were classifie on the basis of amino
acid motifs and the number of cysteine residues in the DBL1a
domain, as proposed elsewhere [21]. This is one of few studies
addressing var expression ex vivo, which adds to understanding
of the clinical relevance of PfEMP1. We assessed diversity using
bioinformatic tools, but this assessment also highlighted the
limitations of the current approach with regard to the identi-
fic tion of specifi subsets of expressed var genes.
MATERIALS AND METHODS
Study samples. Samples were collected during a case-control
study in Madang, Papua New Guinea, as described elsewhere
[23]. Ethical clearance for this study was obtained from the
Papua New GuineaMedical Research Advisory Committee. The
blood samples analyzed were obtained from the following
groups: (1) 15 children with severe malaria, including 4 cases
with cerebral malaria as define by the World Health Orga-
nization [24]; (2) 29 children with mild cases of malaria and
no further symptoms of another disease; and (3) 34 age-
matched children who were parasitemic but asymptomatic.
Isolation of var transcripts and complementary DNA
(cDNA) synthesis. Blood samples were treated with ethylene-
diaminetetraacetic acid and blood pellets were used for var
mRNA isolation and reverse transcription, as described else-
P. falciparum var Gene Expression in Children • JID 2009:200 (1 August) • 349
Table 1. Number of var Transcripts Detected, According to Clinical Status of Subjects
with Malaria
Sequence, clinical status
Total
var sequences, no.
Different
var sequences, no.
Mean no./
child (range)
5′UTR-DBL1a
upsA
All 133 19 0.4 (0–3)
Asymptomatic 4 1 0 (0–1)
Uncomplicated 107 13 0.6 (0–3)
Severe 22 5 0.4 (0–2)
upsB
All 607 78 4.3 (0–13)
Asymptomatic 227 28 3.2 (0–11)
Uncomplicated 252 28 4.8 (0–13)
Severe 128 22 5.1 (0–9)
upsC
All 603 51 2.4 (0–6)
Asymptomatic 256 21 2.3 (0–6)
Uncomplicated 237 22 2.3 (0–6)
Severe 110 8 2.8 (0–5)
Total
1343 148 7.1 (0–14)
DBL1a domain only
Total DBL1a-only
sequences, no.
Different DBL1a-only
sequences, no.
Asymptomatic 482 148 6.3 (1–14)
Uncomplicated 280 141 6.7 (2–14)
Severe 163 75 6.1 (1–9)
Total 925 364 6.4 (1–14)
where [25]. In brief, parasite RNA was immediately extracted
using TRIzol (Invitrogen) in accordance with the manufac-
turer’s instructions. TRIzol extraction was repeated and RNA
was treated twice with RQ1 DNase (Promega). Full-length var
transcripts were obtained by incubation of RNAwith biotinylat-
ed oligonucleotides complementary to exon 2 and captured by
use of streptavidin-linked Dynal beads (Dynal, UK). Reverse
transcription was performed on captured hybrids using Sen-
siscript reverse transciptase (Qiagen). Sample aliquots without
reverse transcriptase served as negative controls.
Amplificatio of DBL1a domain and var group-specifi
PCR. Degenerated DBL1a-5′ and DBL1a-3′ primers were
used to amplify DBL1a-domains, as described elsewhere [25]
(hereafter referred to as “DBL1a-only”). Upstream sequences
were amplifie using var group A-, B-, and C-specifi forward
primers (figu e 1) and DBL1a-3′ reverse primers, resulting in
products of approximately 1.4 kb (hereafter referred to as
“5′UTR-DBL1a”). PCR conditions were as follows: 5 min at
94C, followed by 35 cycles of 30 s, 95C; 60 s, 52C; and 90
s, 68C. PCR products were purifie using the High Pure PCR
Purifi ation Kit (Roche).
Cloning and sequencing. PCR products were processed for
sequencing as described elsewhere [25]. In brief, fragments were
ligated into pGEM-T (Promega) or pET vectors for TOPO
cloning (Invitrogen), in accordance with the manufacturer’s
instructions, and transfected into Escherichia coli SURE cells
(Stratagene). If possible, a mean of 20 clones (range, 2–40)
were picked per transfection and sequenced using the forward
primer T7 (pGEM-T) or M13 (TOPO).
Sequence analysis. Sequences were checked and edited us-
ing MT Navigator (ABI; version 1.02b3), DNASTAR (version
4), NCBI BLAST, and ClustalW.
In general, a consensus sequence was represented by several
sequences from the same transfection. Sequences were consid-
ered identical if they differed by !5 nucleotides. Nucleotide
sequences were translated using ExPASY translation tool and
checked for identity using a 95% identity cutoff.
Sequences were classifie on the basis of the number of
cysteine residues and specifi amino acid motifs (positions of
limited variability [PoLV]) within DBL1a domains, as proposed
by Bull et al. [21]. DBL1a sequences were assigned to 1 of 6
groups and their distribution was analyzed with regard to var
groups A, B, and C and the clinical status of the child from
whom the sequences were isolated.
Multiple sequence alignments were performed in ClustalX
(version 1.83) and unrooted, minimum evolution phylogenetic
trees (based on amino acids and p-distance) were created with
1000 bootstrap replicates by use of Molecular Evolutionary
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Figure 2. Grouping of different DBL1a sequences into 6 sequence
groups, according to the classification model of Bull et al. [31]. A, Dis-
tribution of DBL1a sequence groups according to var subgroup (groups
A, B, and C); B, Distribution of DBL1a sequence groups according to
clinical status.
Genetics Analysis software (MEGA 3.1). Multidimensional scal-
ing analysis (MDS) and analysis of similarities (ANOSIM) were
performed using Primer (version 6.1.9; Primer-E). One-way
ANOSIM, a nonparametric permutation procedure (999 per-
mutations), tests the null hypothesis that there is no difference
between 2 groups and is based on a Poisson-corrected distance
matrix of amino acid sequences, as is MDS, a nonmetric mul-
tivariate ordination method.
All sequences have been submitted to GenBank (accession
numbers are EU787517-EU787985).
Statistical analysis. Intercooled Stata (version 8.2; Stata)
was used to perform Fisher’s exact and Mann-Whitney U tests.
All tests were 2-tailed, and differences were considered signif-
icant if P was !.05.
Species richness estimation. For sequence richness deter-
mination, sequences from Papua New Guinea were compared
to a sequence set from Tanzania (J.P. Mugasa et al., unpublished
data), to sequence data from Mali [19], and a global sequence
collection [26]. DBL1a sequences from all samples were com-
pared to each other by use of BLASTCLUST [27]. Sequences
with 95% identity were assigned the same sequence type. The
number of sequence types depended on how many samples
were taken into account. Perl scripts were developed to simulate
the sequential inclusion of all samples in all possible combi-
nations. Accumulation curves were generated by plotting the
increase in recovery of new sequences as a function of sampling
effort.
RESULTS
Sequence data on 5′UTR-DBL1a was available for 24 of 34
asymptomatic children, 29 of 29 children with mild malaria,
and 14 of 15 children with severe malaria. DBL1a-only se-
quences were available for 28 of 34 asymptomatic children, 23
of 29 children with mild malaria, and 14 of 15 children with
severe malaria (table 1). Failure to obtain sequence data from
all samples was mainly the result of failure to amplify cDNA
for this particular stretch of the sequence. DBL1a-only se-
quences were primarily used to analyze the diversity of var
transcripts, whereas phylogenetic analyses were performed on
5′UTR-DBL1a sequences.
var group distribution in clinical subgroups. Using msp2
genotyping [28], a mean multiplicity of infection of 1.4 in-
fecting strains per child was determined, as described elsewhere
[23], with no association between the number of infecting
strains and the clinical outcome. We found a mean of 6.4
different DBL1a-only sequences per child, with no statistically
significan differences observed between asymptomatic chil-
dren, children with mild malaria, and children with severe ma-
laria, even when adjusting for the number of infecting parasite
strains. var group B and C transcripts were found in equal
numbers in the 3 clinical subgroups, but only 1 var group A
sequence was observed in 1 child with asymptomatic malaria
(table 1).
Of 109 group C 5′UTR-DBL1a sequences, 27 (24.8%) were
detected in more than 1 child, but only 11 (4.8%) of 231 group
B sequences were shared ( , by Fisher’s exact test). MostP ! .001
var group B or C sequences found in 11 child were found in
either asymptomatic children or children with mild malaria; in
these 2 groups, only 19 group A sequences were detected, of
which none was shared.
Distribution of motifs in DBL1a sequences. The sequences
from block D (ARSFADIGDI) to block H (WFEEW) (fi ure
1) [9] of all DBL1a sequences were grouped according to the
number of cysteines in this region and PoLV [21]. Figure 2A
shows the distribution of sequence groups 1 to 6 according to
var group A, B, or C transcripts. The majority of var group B
and C transcripts contained sequences of group 4–6, with group
4 being the dominant. var group A contained group 1–3 se-
quences almost exclusively.
Group 1–3 sequences have been previously shown more
likely to be associated with severe disease [19–21, 29–31]. Al-
though the majority of the var transcripts observed in this study
belonged to var group 4–6 (figu e 3B), group 1–3 sequences
were significantl less common in asymptomatic children than
in children with clinical malaria ( , by Fisher’s exactPp .007
test) (figu e 2B). A detailed analysis of transcripts and asso-
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Figure 3. Unrooted minimum evolution, consensus radial tree (1000 bootstrap replicates; bootstraps above are 50% indicated) of the var N-terminal
segment (NTS)–DBL1a amino acid stretch of study var transcripts, with 3D7 var genes used as a reference (study sequences are labeled as follows:
blue squares, var sequences detected in several children; green circles, sequences with the Y motif in block B of DBL1a; red triangle, an identical
NTS-DBL1a sequence found in 2 children with cerebral malaria; and yellow diamonds, var sequences of rosetting isolates). The labeling of the study
sequences is as follows: (1) the small letters “a,” “u,” or “s” indicate asymptomatic, uncomplicated (i.e., mild), or severe malaria; (2) the first number
refers to the age of the child in months; (3) the capital letters “A,” “B,” or “C” indicate the var group; (4) the number following the var group indicator
corresponds to the sequence number. Successive sets of small letters and numbers indicate the same sequence found in several children.
ciations with sequence length and PoLV motifs can be found
in the appendix, which appears only in the online version of
the Journal
Upstream region of DBL1a-only sequences. The impor-
tance of upstream regions for classificatio of var genes has
been recognized, but this information is difficul to determine.
To test whether comparison of DBL1a sequences with the 3D7
genome might predict the upstream region in fiel samples, we
used BLAST on DBL1a domains of UTR-DBL1a sequences for
which we knew the upstream sequence, to compare with the
3D7 genome to determine the var group in silico.
DBL1a domains in linkage with var group A sequences were
correctly determined in all but 1 case (17 of 18 sequences),
whereas 21 (28.4%) of 74 group B sequences were incorrectly
allocated to var group C, and 30 (62.5%) of 48 confir ed group
C sequences were wrongly assigned to var group B. Overall,
sequence similarity analysis comparing DBL1a with 3D7 led
to incorrect assignments for 51 (36.4%) of 140 sequences.
Phylogenetic analysis of NTS-DBL1a sequences. A dis-
tance matrix–based, radial phylogenetic tree of NTS-DBL1a
sequences with the var transcripts obtained and with 3D7 var
genes as reference indicated 7 main clusters (figu e 3). Several
clusters had an increased proportion of var sequences with
specifi characteristics as described below.
First, the var group A cluster was the only cluster clearly
separated, and transcripts from rosetting parasites were found
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Figure 4. Multiple sequence alignment of DBL1a block A from cysteine 1 to cysteine 3. Selection of study and 3D7 var sequences with amino
acid differences; differences between groups are indicated by bold type.
in this group. Second, clusters with commonly expressed var
genes that were found in several children were mainly grouped
into 2 clusters (figu e 3, blue clusters). One cluster comprised
group B and C transcripts and three 3D7 var genes of the
intermediate groups BA or BC, representing var genes with
complex domain structures, including DBL2b-C2. In 2 of 4
children with cerebral malaria, the group C sequence
s44s36a35C13 was observed to be the most abundant after
cloning and sequencing. The second cluster also contained a
mixture of group B and C sequences, which exclusively clus-
tered with 3D7 var group B sequences.
Third, var group C cluster comprised mainly var group C
or BC sequences (figu e 3, green cluster). Two closely related
sequences (a59C6 and a38C5) originated from 2 children with
asymptomatic malaria but very high parasitemia of 108,000 and
44,000 parasites/mL, respectively, and low hemoglobin levels.
These var group C sequences were the dominant var transcripts
(7 of 31 and 10 of 15 sequenced clones) in these children, and
no var group A or B transcript was amplified confir ing pre-
vious quantitative PCR data [24]. These sequences have a dis-
tinct DBL1a block A with a cysteine-to-tyrosine substitution
(figu e 4). Subsequently, this substitution was found in 19 dif-
ferent var transcripts, of which 14 were var group C genes.
Fourteen of these sequences had a cysteine 7 aa further down-
stream instead. These 19 sequences were derived from 18 chil-
dren (median age, 46 months; 4 children had severe malaria,
5 had mild malaria, and 9 were asymptomatic) who had a
parasitemia level 7 times higher (median parasitemia level,
64,000 parasites/mL) than that of children not expressing this
var variant (median parasitemia level, 8,920 parasites/mL)
( , by use of the Mann-Whitney U test).Pp .067
Clustering of var transcripts of severe and asymptomatic
malaria cases. Although there was no obvious clustering of
full-length NTS-DBL1a sequences of severe malaria cases, an
MDS plot showed statistically significan clustering of the
DBL1a stretch from block E to F [9] (figu e 5 and fi ure A4,
which appears only in the online appendix) of dominant var
transcripts from children with severe malaria and children with
asymptomatic malaria (ANOSIM test, ). In particular,Pp .002
7 of 12 var sequences from children with severe malaria were
clearly grouped apart (figu e 5), a result that is also evident in
a distance tree of this sequence stretch that contains all var
transcripts (figu e A4). This distinct cluster contained var tran-
scripts of parasites from 14 children, 7 of whom had severe
malaria ( , by use of Fisher’s exact test). var transcriptsPp .006
expressed in 3 of 4 children with cerebral malaria were also
grouped in this cluster ( , by use of Fisher’s exact test).Pp .025
Species richness determination. To estimate the diversity
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Figure 5. Multidimensional scaling analysis reflecting a distance matrix of var sequences between semiconserved DBL1a blocks E and F from
children with severe (black triangles), mild (crosses), and asymptomatic malaria (gray circles). Letters A, B, and C indicate the var groups of these
sequences.
of var DBL1a sequences, we simulated species accumulation
curves based on four data sets (figu e 6). For each data set, the
number of DBL1a sequence types was plotted against the num-
ber of samples studied, and empirical plots were well fitte by
a linear function. The different nonparametric estimators of
species richness implemented in Eco-Tools (http://www.eco
-tools.net) were applied to all data sets, but none was stabilized
before reaching the full number of samples.
In all cases, curves did not reach a plateau, which indicated
that the diversity of DBL1a sequences is vast, and more sam-
pling efforts are needed to completely capture sequence diver-
sity. The slopes of the curves varied among data sets (fi ure
6), reflectin different sequence diversity. Other factors also
contributed to the observed differences, such as the source of
sequences (cDNA or genomic DNA) or the number of clones
sequenced per sample.
DISCUSSION
Little information is available on var gene expression in nat-
urally infected malaria cases [19–23, 32]. To describe the ex-
pression of var genes, we conducted a case control study in
Papua New Guinea and analyzed var transcripts of parasites
isolated from 78 children with asymptomatic, mild, and severe
malaria.
There was not a statistically significan difference between
asymptomatic, mild, and severe malaria cases with respect to
the number of different var transcripts of group B or C detected
by cloning and sequencing, which is in accord with the data
fromMali [19]. We previously reported a statistically signifi ant
quantitative shift from var group B to group C transcripts in
the same symptomatic and asymptomatic malaria cases, dem-
onstrated by real-time PCR [23]. However, quantitative analysis
based on cloning and sequencing of PCR products introduces
bias through primers, amplificatio plateaus, and cloning and
cannot be compared directly with quantitative PCR [33]. A
combination of quantitative and qualitative information about
var transcripts provides the most meaningful data.
An increase in the number of var group A transcripts in
children with symptomatic malaria was observed, compared
with the result for children with asymptomatic malaria. This
is in agreement with the results of a study by Bull et al. [21]
and subsequent studies [19, 29–31], which showed that DBL1a
sequences of cys2 type (groups 1–3, mainly var group A genes)
were primarily found in children with symptomatic malaria.
This shift in the distribution of DBL1a groups between clinical
presentations was only evident for dominantly expressed
sequences.
A total of 370 different DBL1a-only sequences were detected,
of which 7% were found in 11 child. Approximately 25% of
all var group C sequences were detected more than once in
several children, whereas only 5% of group B sequences were
shared. This indicates a larger diversity of var group B than
would be expected from the ratio of var group B to C genes
per genome, which is only 3 in 3D7. This fi ding supports
previous studies that reported high recombination rates, es-
pecially between group B genes [30, 34–36]. Phylogenetic anal-
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Figure 6. Comparison of P. falciparum erythrocyte membrane protein 1 DBL1a accumulation curves simulated for different data sets. Asterisks,
Mali; Tanzania; dotted line, Papua New Guinea; global. The value on the x-axis is the no. of patient samples or cloned isolates studied. The data set
is described in the table below the figure.
yses also suggested frequent genetic exchange between group
B and C genes because they did not cluster separately, and we
were unable to determine the respective var groups of DBL1a
sequences by use of BLAST analysis.
Only 15 children with severe malaria (including 4 with ce-
rebral malaria) were admitted to the hospital during the 4-
month study period. The low incidence of severe malaria has
been attributed to good access to antimalarials, the omnipres-
ence of P. vivax, and the genetic background of Papua New
Guineans [37]. Therefore, findin the same var NTS-DBL1a
sequence dominantly transcribed in 2 of 4 children with ce-
rebral malaria was surprising. In a distance tree, this sequence
clustered with other frequently detected var transcripts andwith
3 genes of complex structure of the 3D7 var group BA/BC
genes. These 3D7 var genes contain additional domains such
as DBL2b-C2, which was previously found to be associated
with cerebral malaria and binding to the intercellular adhesion
molecule–1 [38–40]. Another of these genes, PFL0020w, was
previously found to be the second most transcribed var gene
in an artificia P. falciparum 3D7 challenge infection in a non-
immune human host [41]. PFL002w has a DBL1a sequence
(DQ519151) identical to that of a var transcript from parasites
isolated from heart tissue obtained from 2 children with fatal
malaria in Malawi [32]. Thus, special attention should be paid
to var genes within this cluster, as they might be strongly as-
sociated with the morbidity of malaria.
Although there was no obvious clustering of NTS-DBL1a
sequences in cases of severe malaria, MDS analysis of block E
to F of DBL1a showed statistically significan sequence clus-
tering of a large subset derived from children with severe ma-
laria. This cluster contained var transcripts from 3 of 4 children
with cerebral malaria, suggesting a restricted subset associated
with severe malaria.
Our findin that a subset of var sequences were associated
with severe disease and detected in several children agrees with
the results of previous studies [16, 18, 42] and suggests the
existence of conserved var genes that are readily expressed in
less-immune hosts, increasing parasite survival by providing
distinct abilities to bind to vital organs.
Two older children with asymptomatic malaria had unusually
high parasitemia levels (140,000 parasites/mL) with no accom-
panying symptoms. Parasites obtained from these children al-
most exclusively expressed only 1 var group C transcript and
previously had shown a strong proportional increase in the
number of var group C transcripts [23]. These 2 sequences
were closely related to each other and the 3D7 var gene
PF08_0107 that was previously associated with weak IgG rec-
ognition in semi-immune children and with high expression
in unselected 3D7 parasites [18]. In these var sequences and
others within a cluster that contained mainly var group C se-
quences, a cysteine was replaced by tyrosine. It remains to be
confi med whether this motif is a marker for a distinct var type
P. falciparum var Gene Expression in Children • JID 2009:200 (1 August) • 355
or whether it is involved in immune recognition or binding.
Such replacement of a cysteine providing disulfid bridges with
an aromatic tyrosine might lead to changes in the tertiary struc-
ture of PfEMP1.
Our findin suggests that var group C genes are primarily
expressed in older, semi-immune hosts who already developed
immunity against those var genes that are involved in severe
pathogenesis. Unselected cultured parasites showed highly ex-
pressed var group C genes (H.P.B., unpublished data, as well
as other studies [18, 43]) with low switch-off rates [43]. This
might explain the exclusive transcription of group C genes in
some semi-immune children. It is as yet unclear whether the
high levels of parasitemia observed in these children were a
result of var group C expression. A “hole in the antibody rep-
ertoire” [18, 44, 45] due to rare expression of some of these
antigens or other strategies to evade protective immune re-
sponses could explain this result. The fact that these children
were asymptomatic despite the high parasitemia levels suggests
that these PfEMP1 molecules did not mediate cytoadherence
in vital organs. In this regard, it is noteworthy that, in a previous
quantitative study, parasite burden was positively associated
with a proportional increase in var group C expression, es-
pecially in older children with asymptomatic malaria (age 136
months; ; Spearman’s ; ) [23].np 14 rp 0.82 P ! .001
In conclusion, we showed that a greater proportion of var
group A or cys2 DBL1a sequences are present in children with
symptomatic malaria than in children with asymptomatic ma-
laria, and we provide evidence that a subset of frequently en-
countered var genes with complex DBL1a structure might be
associated with more severe forms of malaria. We also described
another subset of var group C genes that are frequently ex-
pressed in older children with asymptomatic high levels of par-
asitemia. However, we were unable to clearly identify an as-
sociation between define var gene expression and severe
malaria. Apart from technical reasons, such as the small number
of severe malaria cases and the challenges inherent in applying
a cloning and sequencing approach to fiel samples, this lack
of association could also result from the fact that the mixture
of parasites found in peripheral blood express many different
var genes, as previously reported by Montgomery et al. [32].
Further research on var gene expression in natural infection
and in different settings is urgently needed to understand the
dynamics of var gene expression and the associated pathogen-
esis. Only then can the innovative, advanced proteomic studies
be facilitated that are needed to identify PfEMP1 molecules that
might become targets of new anti-disease interventions.
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